跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VERRUCUTAN 5 MG/G + 100 MG/G SOLUCION CUTANEA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VERRUCUTAN 5 MG/G + 100 MG/G SOLUCION CUTANEA
Approved
STANDARD
VERRUCUTAN 5 MG/G + 100 MG/G SOLUCION CUTANEA
Mibe Pharma España S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 6, 2021
Approval ID
663279784e77a6b5
Company
Mibe Pharma España S.L.U.
Type
Standard
Approval Details
Approval Id
663279784e77a6b5
Drug Cima Aemps Name
VERRUCUTAN 5 MG/G + 100 MG/G SOLUCION CUTANEA
Register Number
86061
Holder Company Name
Mibe Pharma España S.L.U.
Marketing Company Name
Mibe Pharma España S.L.U.
Authorization Date
2021-09-06
Dosage Form
SOLUCIÓN CUTÁNEA
Dose
5 mg/g + 100mg/g
Route Of Administration
USO CUTÁNEO
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Mibe Pharma España S.L.U.
Active Ingredients
FLUOROURACILO
5 mg
SALICILICO ACIDO
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 6, 2021
Approval ID
663279784e77a6b5
Type
Standard
Back to CIMA-AEMPS Approvals
